Mobile

A clinical study to investigate the safety and efficacy of the product rhuMAb BETA7 in treating patients with ulcerative colitis, a form of inflammatory bowel disease Ensayo clínico para investi...

Update Il y a 4 ans
Reference: EUCTR2011-000897-80

A clinical study to investigate the safety and efficacy of the product rhuMAb BETA7 in treating patients with ulcerative colitis, a form of inflammatory bowel disease Ensayo clínico para investigar la seguridad y eficacia del producto rhuMab Beta7 en tratamiento de pacientes con colitis ulcerosa, una enfermedad inflamatoria del intestino grueso

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

The primary objective of this study is to evaluate the efficacy of different doses of rhuMAb Beta7 compared with placebo in patients with moderate to severe UC. El objetivo principal de este estudio consiste en evaluar la eficacia de diferentes dosis de rhuMAb Beta7 en comparación con placebo en pacientes con CU moderada o grave.

Inclusion criteria

  • Ulcerative colitis,Colitis Ulcerosa

Links